Literature DB >> 22488634

Doppler ultrasound of hepatic blood flow for noninvasive evaluation of liver fibrosis compared with liver biopsy and transient elastography.

H H Lutz1, N Gassler, F W Tischendorf, C Trautwein, J J W Tischendorf.   

Abstract

BACKGROUND: Accurate quantification of liver fibrosis is essential for therapeutic decision-making and follow-up of chronic liver diseases. AIMS: To optimize the quality of non-invasive assessment of liver fibrosis in patients with chronic hepatopathy we compared Doppler ultrasound with liver histology and transient elastography (TE).
METHODS: In this prospective observational study, we performed Doppler ultrasound of hepatic blood vessels as well as TE in 125 patients who underwent liver biopsy for diagnostic work-up of hepatopathy. Hepatic venous flow was evaluated by determining resistance index (HVRI) of the right hepatic vein. Doppler and TE results were compared with histological staging, grading and degree of steatosis obtained by liver biopsy.
RESULTS: HVRI showed a high reliability in predicting fibrosis stage FII or higher (AUROC 93.7 %, HVRI < 1.185; sensitivity 89.66 % and specificity 86.32 %) and was superior to TE. Neither steatosis nor inflammation had significant influence on HVRI-based estimation of fibrosis (1.45 ± 0.2; 1.26 ± 0.05; 1.06 ± 0.06; 0.87 ± 0.08; 0.46 ± 0.11 for F0-FIV, respectively). HVRI differed significantly in different stages of fibrosis. In contrast, portal vein and hepatic artery only showed significant changes in higher stages of fibrosis. Hepatic artery resistance index was elevated (0.67-0.74; p < 0.05); portal vein flow maximum and undulation were significantly reduced in higher fibrosis (p < 0.05 and p < 0.01, respectively).
CONCLUSIONS: Hepatic blood flow analysis, especially HVRI, provides useful information during assessment of hepatopathy and is a reliable predictor of liver fibrosis stage FII or higher as part of the non-invasive diagnostic work-up and follow-up in chronic liver disease.

Entities:  

Mesh:

Year:  2012        PMID: 22488634     DOI: 10.1007/s10620-012-2153-0

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  37 in total

1.  Diffusion-weighted MRI versus transient elastography in quantification of liver fibrosis in patients with chronic cholestatic liver diseases.

Authors:  Jelena Djokić Kovač; Marko Daković; Dejana Stanisavljević; Tamara Alempijević; Rada Ješić; Petar Seferović; Ružica Maksimović
Journal:  Eur J Radiol       Date:  2011-11-17       Impact factor: 3.528

2.  Hepatic and portal vein flow pattern in correlation with intrahepatic fat deposition and liver histology in patients with chronic hepatitis C.

Authors:  C F Dietrich; J H Lee; R Gottschalk; G Herrmann; C Sarrazin; W F Caspary; S Zeuzem
Journal:  AJR Am J Roentgenol       Date:  1998-08       Impact factor: 3.959

3.  EASL Clinical Practice Guidelines: management of hepatitis C virus infection.

Authors: 
Journal:  J Hepatol       Date:  2011-03-01       Impact factor: 25.083

4.  Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C.

Authors:  Laurent Castéra; Julien Vergniol; Juliette Foucher; Brigitte Le Bail; Elise Chanteloup; Maud Haaser; Monique Darriet; Patrice Couzigou; Victor De Lédinghen
Journal:  Gastroenterology       Date:  2005-02       Impact factor: 22.682

5.  Association between duplex Doppler sonographic flow pattern in right hepatic vein and various liver diseases.

Authors:  A von Herbay; T Frieling; D Häussinger
Journal:  J Clin Ultrasound       Date:  2001-01       Impact factor: 0.910

6.  Reliability of transient elastography for the detection of fibrosis in non-alcoholic fatty liver disease and chronic viral hepatitis.

Authors:  Silvia Gaia; Silvia Carenzi; Angela L Barilli; Elisabetta Bugianesi; Antonina Smedile; Franco Brunello; Alfredo Marzano; Mario Rizzetto
Journal:  J Hepatol       Date:  2010-08-21       Impact factor: 25.083

7.  Comparison of eight diagnostic algorithms for liver fibrosis in hepatitis C: new algorithms are more precise and entirely noninvasive.

Authors:  Jérôme Boursier; Victor de Ledinghen; Jean-Pierre Zarski; Isabelle Fouchard-Hubert; Yves Gallois; Frédéric Oberti; Paul Calès
Journal:  Hepatology       Date:  2012-01       Impact factor: 17.425

8.  Liver cirrhosis: changes of Doppler waveform of hepatic veins.

Authors:  L Bolondi; S Li Bassi; S Gaiani; G Zironi; G Benzi; V Santi; L Barbara
Journal:  Radiology       Date:  1991-02       Impact factor: 11.105

9.  Liver stiffness measurement using FibroScan is influenced by serum total bilirubin in acute hepatitis.

Authors:  Seung Up Kim; Kwang-Hyub Han; Jun Yong Park; Sang Hoon Ahn; Moon Jae Chung; Chae Yoon Chon; Eun Hee Choi; Do Young Kim
Journal:  Liver Int       Date:  2008-10-24       Impact factor: 5.828

10.  Damping index of Doppler hepatic vein waveform to assess the severity of portal hypertension and response to propranolol in liver cirrhosis: a prospective nonrandomized study.

Authors:  Moon Young Kim; Soon Koo Baik; Dong Hun Park; Dae Wook Lim; Jae Woo Kim; Hyun Soo Kim; Sang Ok Kwon; Young Ju Kim; Sei Jin Chang; Samuel S Lee
Journal:  Liver Int       Date:  2007-10       Impact factor: 5.828

View more
  9 in total

1.  Measuring fibrosis: is seeing really believing?

Authors:  Tuyet A T Nguyen; Richard K Sterling
Journal:  Dig Dis Sci       Date:  2012-08       Impact factor: 3.199

2.  Doppler Ultrasound and Transient Elastography in Liver Transplant Patients for Noninvasive Evaluation of Liver Fibrosis in Comparison with Histology: A Prospective Observational Study.

Authors:  H H Lutz; B Schroeter; D C Kroy; U Neumann; C Trautwein; J J W Tischendorf
Journal:  Dig Dis Sci       Date:  2015-05-14       Impact factor: 3.199

3.  Clinical characteristics of cirrhosis patients with umbilical vein recanalization: A retrospective analysis.

Authors:  Qing Shi; Kai Xiong; Bin Ding; XiaoLing Ye
Journal:  Medicine (Baltimore)       Date:  2021-09-03       Impact factor: 1.817

4.  Transvenous hepatic biopsy in stable Fontan patients undergoing cardiac catheterization.

Authors:  William N Evans; Brody J Winn; Noel S Yumiaco; Alvaro Galindo; Abraham Rothman; Ruben J Acherman; Humberto Restrepo
Journal:  Pediatr Cardiol       Date:  2014-05-10       Impact factor: 1.655

5.  Spontaneous resolution of portal vein thrombosis in cirrhosis: where do we stand, and where will we go?

Authors:  Xingshun Qi; Zhiping Yang; Daiming Fan
Journal:  Saudi J Gastroenterol       Date:  2014 Sep-Oct       Impact factor: 2.485

6.  Large-volume paracentesis effects plasma disappearance rate of indo-cyanine green in critically ill patients with decompensated liver cirrhosis and intraabdominal hypertension.

Authors:  Ulrich Mayr; Leonie Fahrenkrog-Petersen; Gonzalo Batres-Baires; Alexander Herner; Sebastian Rasch; Roland M Schmid; Wolfgang Huber; Tobias Lahmer
Journal:  Ann Intensive Care       Date:  2018-07-06       Impact factor: 6.925

7.  Ultrasound shear wave elastography and liver biopsy to determine liver fibrosis in adult patients.

Authors:  Mohammad M Gharibvand; Mohammad Asare; Azim Motamedfar; Pezhman Alavinejad; Mohammad Momeni
Journal:  J Family Med Prim Care       Date:  2020-02-28

8.  Radiomics based on fluoro-deoxyglucose positron emission tomography predicts liver fibrosis in biopsy-proven MAFLD: a pilot study.

Authors:  Zhong-Wei Chen; Kun Tang; You-Fan Zhao; Yang-Zong Chen; Liang-Jie Tang; Gang Li; Ou-Yang Huang; Xiao-Dong Wang; Giovanni Targher; Christopher D Byrne; Xiang-Wu Zheng; Ming-Hua Zheng
Journal:  Int J Med Sci       Date:  2021-09-07       Impact factor: 3.738

9.  Evaluation of hepatic tissue blood flow using xenon computed tomography with fibrosis progression in nonalcoholic fatty liver disease: comparison with chronic hepatitis C.

Authors:  Ryuta Shigefuku; Hideaki Takahashi; Masaki Kato; Yoshihito Yoshida; Keigo Suetani; Yohei Noguchi; Moriaki Hatsugai; Kazunari Nakahara; Hiroki Ikeda; Minoru Kobayashi; Kotaro Matsunaga; Nobuyuki Matsumoto; Chiaki Okuse; Fumio Itoh; Shiro Maeyama; Shigeru Sase; Michihiro Suzuki
Journal:  Int J Mol Sci       Date:  2014-01-14       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.